Navigation Links
Arcxis Biotechnologies Announces Release of First Commercial Product for Molecular Analysis
Date:10/4/2009

Arcxis Biotechnologies® announces the launch of ArcPure™ viral DNA and viral RNA sample preparation kits for life science and clinical laboratories.

Pleasanton, CA (PRWEB) October 4, 2009 -- Arcxis Biotechnologies is pleased to announce the availability of their first commercial product line: the ArcPure™ line of nucleic acid isolation and purification kits. These sample preparation kits are optimized to extract and purify viral DNA and RNA from plasma and whole blood. The ArcPure kits are designed to increase downstream assay sensitivity, a critical component of the molecular analytical process. In addition, the product line offers an exceptionally cost effective approach to efficient and expeditious extraction, purification and concentration of nucleic acids using standard laboratory equipment.

The ArcPure line leverages components of the company's patented automated molecular system technologies, currently under development. As such, the kits offer technologists and investigators cutting edge performance in a familiar format, at a significantly lower cost than standard commercially available products. "We were inspired to develop the ArcPure spin-column technology based on the superior performance of Xisyl™, our pre-market automated sample preparation system", commented Arcxis Biotechnologies CEO, Chris Meda. "We are proud of the superior quality of the kits and pleased to offer a robust, cost-effective option to researchers and clinical laboratorians alike."

The ArcPure Sample Preparation kits will initially be available for purchase via the Arcxis e-commerce site, beginning October first.

About Arcxis:
Led by a seasoned team with decades of success in research & development, commercialization and market insight, Arcxis Biotechnologies is focused on developing elegant and cost-effective solutions to today's molecular diagnostic challenges. Incorporated in November 2004, the company holds numerous patents and currently supports its advances in molecular sample processing, target detection, microfluidics and workflow automation with both venture funds (Claremont Creek Ventures, Kaiser Permanente Ventures, Alafi Capial, In-Q-Tel) and cohesive collaborations with leading industry and academic organizations.

For more information about Arcxis Biotechnologies or to order ArcPure Sample Preparation kits, visit: www.arcxis.com/.

###

Read the full story at http://www.prweb.com/releases/2009/10/prweb2984974.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement
2. Millennium Biotechnologies Inc. Signs Five Year $20,000,000 Purchase Agreement with Provider Services Inc. of Cleveland, Ohio
3. MDS Analytical Technologies Acquires Blueshift Biotechnologies
4. Veteran of the Beverage Industry, Ken Sadowsky, Joins Millennium Biotechnologies Board of Directors
5. Ezra Van Gelder Joins Microchip Biotechnologies as Executive Vice President R&D
6. Millennium Biotechnologies Reports Strong Third Quarter Revenue and Financial Results
7. Therapure Biopharma Inc. and LFB Biotechnologies Announce Development Services Contract for New Therapeutic Protein
8. Epeius Biotechnologies Rexin-G Receives FDA Fast Track Designation for the Treatment of Pancreatic Cancer
9. TriLink BioTechnologies, Inc. Announces Sales and License Agreement With Glen Research Corporation for CleanAmp(TM) Amidites
10. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
11. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... Louis, MO (PRWEB) , ... January 16, 2017 , ... St. Louisans are well-aware of ... here , This year’s influenza shot seems to be having no effect on ... area, at least half of the people around are coughing, sneezing, or sniffling ...
(Date:1/16/2017)... CITY, UT (PRWEB) , ... January 16, 2017 , ... ... disease not only to treat, but to test for, as well. The money spent ... billion every year.(1) Doctors in the U.S. screen patients for cancer more than in ...
(Date:1/15/2017)... York, NY (PRWEB) , ... January 15, 2017 , ... ... strategic accounts in the United States for the asthma & allergy friendly mark. This ... America to independently test and identify consumer products to be more suitable for the ...
(Date:1/15/2017)... ... January 15, 2017 , ... "On Tour is a music themed slideshow ... ease," said Christina Austin - CEO of Pixel Film Studios. , On Tour’s ... the style and animation of their slideshows. Place each slide on top of another ...
(Date:1/15/2017)... ... January 15, 2017 , ... The ... is pleased to announce that it will be assisting HackensackUMC Mountainside with its ... Glen Ridge townships, servicing all surrounding towns. The firm will be working closely ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... -- This morning, Stock-Callers.com draws attention to ... at yesterday,s closing bell: Clovis Oncology Inc. (NASDAQ: ... GALE ), and ACADIA Pharmaceuticals Inc. (NASDAQ: ... to develop technologies and products that combat debilitating and ... use less and cleaner energy, and provide safer, cleaner ...
(Date:1/13/2017)... -- The 2016 election resulted in a big ... in favor of legalizing cannabis for recreational use, including ... U.S. In addition, the state of Colorado ... sales. The ArcView Group has published an updated research report ... in the U.S. last year reached $6.7 billion, a growth of ...
(Date:1/13/2017)... NEW YORK , Jan. 12, 2017 /PRNewswire-USNewswire/ ... type 1 diabetes (T1D) research, is pleased to ... advocacy efforts, the Centers for Medicare & Medicaid ... devices approved by the FDA for use in ... a significant step toward making them eligible for ...
Breaking Medicine Technology: